Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shui O, Leung"'
Autor:
Kin L. Wong, Zhengdong Li, Felix Ma, Dong Wang, Nan Song, Chi H. Chong, Ka K. Luk, Shui O. Leung
Publikováno v:
The Journal of Immunology. 208:2726-2737
SM03, an anti-CD22 recombinant IgG1 mAb, is currently in a phase III clinical trial for the treatment of rheumatoid arthritis (NCT04312815). SM03 showed good safety and efficacy in phase I systemic lupus erythematosus and phase II moderate to severe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61c8e9e100c601f8f269db61bac91879
https://doi.org/10.4049/jimmunol.2100820
https://doi.org/10.4049/jimmunol.2100820
Autor:
Kin L, Wong, Zhengdong, Li, Felix, Ma, Dong, Wang, Nan, Song, Chi H, Chong, Ka K, Luk, Shui O, Leung
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 208(12)
SM03, an anti-CD22 recombinant IgG1 mAb, is currently in a phase III clinical trial for the treatment of rheumatoid arthritis (NCT04312815). SM03 showed good safety and efficacy in phase I systemic lupus erythematosus and phase II moderate to severe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be860b4ccd110fddfdb3aef171506590
https://pubmed.ncbi.nlm.nih.gov/35688465
https://pubmed.ncbi.nlm.nih.gov/35688465